Steven Cohen I Teos Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$10.95 - $14.6 $10,084 - $13,446	921 New	921 $10,000
Q1 2023 May 15, 2023	BUY	$13.02 - $22.62 $47,132 - $81,884	3,620 New	3,620 $49,000
Q1 2022 May 16, 2022	SELL	$31.92 - $47.45 $3.35 Million - $4.98 Million	-105,030 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$26.23 - $47.86 $2.75 Million - $5.03 Million	105,030 New	105,030 $4.89 Million

166

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $257M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.